Anti-TNFα antibody therapy has been demonstrated to exhibit robust anti-tumor effects in mouse models of pancreatic cancer and achieve disease stabilization in individuals with diagnoses of metastatic breast and recurrent ovarian cancer (27–29). The gene discussed is TNF; the disease is ovarian cancer.